Bievre Epargne Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
2
- Exits
-
2
Bievre Epargne General Information
Company Description
Bievre Epargne was a venture capital firm based in Paris, France.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 16 Place de la Madeleine
- 75008 Paris
- France
Bievre Epargne Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Phoska Biopharma | 31-Mar-2023 | Seed Round | Biotechnology | Startup | ||
| Opuscope | 27-Nov-2019 | Multimedia and Design Software | Out of Business |
Bievre Epargne Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Opuscope | 20-Aug-2024 | Out of Business | |
| Phoska Biopharma |
Bievre Epargne Investments by Industry, Year, and Region
Bievre Epargne Co-Investors (3)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Albrekca | 1 |
|
|
||
| Peter Kadas |
|
|
|||
| SPRIM Global Investments |
|
|
Bievre Epargne FAQs
-
What is Bievre Epargne?
Bievre Epargne was a venture capital firm based in Paris, France.
-
Where is Bievre Epargne headquartered?
Bievre Epargne is headquartered in Paris, France.
-
How many investments has Bievre Epargne made?
Bievre Epargne has made 2 investments.
-
What has Bievre Epargne invested in?
Bievre Epargne has made numerous investments in companies like Phoska Biopharma and Opuscope within the Biotechnology and Multimedia and Design Software industries.
-
What has Bievre Epargne invested in recently?
Bievre Epargne's latest investment was on 31-Mar-2023 in Phoska Biopharma, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process